Freis, E.D., Partenope, E.A., Lilienfield, S.S., AND Rose, J.C.: A clinical appraisal of pentapyrrolidium (17 & B. 2050) in hypertensive patients. Circulation, 9: 540, 1954.
2.
Freis, E.D.: The discrepancy between home and office recordings of blood pressure in patients under treatment with pentapyrrolidinium. Importance of home recordings in adjusting dosages. M. Ann. District ofColumbia, 23: 1, 1954.
3.
Freis, E.D.: The management of hypertension. A nationwide, closed circuit television symposium under the auspices of the American College of Physicians, September, 1954.
4.
Hafkenschiel, J.H., AND Lindauer , M.A.: 1-Hydrazinophthalazine (Apresoline) in the treatment of hypertension: a two year study. Circulation, 7: 1, 1953.
5.
Jeffers, W.A.: Evaluation of the patient with hypertension. In Advances in Medicine and Surgery, p. 130. W. B. Saunders Company, Philadelphia, 1952.
6.
Smithwick, R.H.: The effects of sympathectomy upon the mortality and survival rates of patients with hypertensive cardiovascular disease. In Hypertension, edited by E. T.Bell, p. 492. University of Minnesota Press, Minneapolis, 1951.
7.
Jeffers, W.A. : Management of patients with essential hypertension. GeneralPractioner, 10: 66, 1954.
8.
Dennis, E., Ford, R., Hirschberger, R., AND Moyer, J.H.: Pentolinium and hexamethonium continued with rauwolfia in the treatment of hypertension. New England J. Med., 253: 597, 1955 .
9.
Crawley, C.J. , Silvas, G.M., Stumpe, W.M., AND Spence, W.: Methium chloride with reserpine, a new anti-hypertensive combination. New YorkJ. Med., 55: 3461, 1955 .
10.
Wagner, H.P. , AND Keith, N.M.: Diffuse arteriolar disease and hypertension and associated retinal lesions. Medicine, 18: 317, 1939.
11.
Fries, E.D. : Veratrum veride and hexamethonium in the treatment of severe diastolic hypertension. M. Ann. DistrictColumbia , 20: 297, 1951.
12.
Smirk, F.H. : Practical details of the methonium treatment of high blood pressure. New Zealand M. J.,49: 637, 1905.
13.
Freis, E.D. , Finnerty, F.A., JR., Schnaper , H.W., AND Johnson, R.L.: The treatment of hypertension with hexamethonium. Circulation,5: 20, 1952.
14.
Grimson, K.S. , Orgain, E.S., Rowe, C.R., JR., AND Sieber , H.A.: Caution with regard to use of hexamethonium and "Apresoline."J. A. M. A.,149: 215, 1952.
15.
Wilkins, R.W. : Rauwolfia in the treatment of essential hypertension. Seminars on anti-hypertensive drugs. Am. J. Med., 17: 703, 1954.
16.
Moyer, J.H. : Cardiovascular and renal hemodynamic response to reserpine (Serpasil) and clinical results of using this agent for the treatment of hypertension. Ann. New YorkAcad. Sc., 59: 82, 1954.
17.
Achor, R.W.P. , Hanson, N.O., AND Gif-Ford , R.W., JR.: Hypertension treated with rauwolfia serpentina (whole root) and with reserpine. J. A. M. A.,159: 841, 1955.
18.
Schroeder, H.A., AND Perry, H.M.J.: Psychosis apparently produced by reserpine . J. A. M. A., 159: 839, 1955.
19.
Muller, J.C. , Pryor, W.W., Gibbons, J.E., AND Orgain, E.S.: Depression and anxiety occurring during rauwolfia therapy. J. A. M. A., 159: 836, 1955 .
20.
Hafkenschiel, J.H.: Medical management of hypertension with particular reference to hypertensive drugs. Wisconsin M. J. , 53: 423, 1954.